Category Archives: Clinical Cardiology

WAYNE, Pa., Nov. Continue reading →

November 8, 2019 Dissection is a frequent and clinically problematic outcome of percutaneous transluminal balloon angioplasty (PTA), and there is no current safe solution for revascularization of below-the-knee (BTK) arteries. The TOBA II BTK Trial looked atusing small stents to tack the vessel if needed without using a full sized stent, which leads to stent fractures BTK. The trial, presented as a late-breaker at the 2019 Vascular Interventional Advances (VIVA) annual meeting, met all endpoints in a 100 percentdissected vessel population Continue reading →

November 8, 2019 The Absorb bioresorbable stent (BVS) demonstrated good patency and clinical outcomes in patients with chronic limb-threatening ischemia (CLTI) in the DISAPEAR Registry. This included complex infrapopliteal disease and comorbidities such as diabetes and renal failure, said Steven Kum, M.D., who presented the trial at the 2019 Vascular Interventional Advances (VIVA) annual meeting. Future prospective controlled studies can further help corroborate the significance of these findings, Kum said Continue reading →

Prespecified Analysis of 3,146 Patients in the USA Enrolled in REDUCE-IT Showed 31% Relative Risk Reductions for First Occurrence of Both 5-Point MACE and 3-Point MACE Significant Reductions Shown in All Predefined Composite and Individual Cardiovascular Endpoints, Including Cardiovascular Death and All-Cause Mortality Tolerability and Safety Findings Consistent with Full Study Results Published Today in Circulation and Scheduled for Presentation at American Heart Association 2019 Scientific Sessions on November 17 DUBLIN, Ireland and BRIDGEWATER, N.J., Nov. Continue reading →

The In-Vitro diagnostic market is valued as a USD 17 billion market in 2013 and is expected to become a USD 25 billion by 2020, growing at a CAGR of 5.66%. Continue reading →

The University of Vermont Health Network has begun a pilot project to offer Genomic DNA Testing to patients as part of their clinical care. The pilot program is the beginning of an effort to increase the integration of genetic disease risks into routine medical care, which holds promise for providing Vermonters with valuable information to guide their health decisions Continue reading →

Radiologists interpreted 99.29% (17,698,360) of CT exams, while nonradiologists read 0.71% (125,937). And of the 4,512,627 MRIs performed, radiologists read 99.04% of those, while their nonradiologist peers interpreted 0.96%. Similar disparities were found among PET and nuclear medicine studies, with cardiologists interpreting about 3% of all advanced imaging exams. Continue reading →

The latest in interventional cardiology clinical data and new device technologies were highlighted at the annual Transcatheter Cardiovascular Therapeutics (TCT) conference. Continue reading →

RENO Following a collaborative recruitment between the University of Nevada, Reno School of Medicine and Carson Tahoe Health, Lorrel Toft, M.D., F.A.C.C., a cardiovascular critical care physician and researcher, has been recruited as an associate professor for UNR Meds Department of Internal Medicine as well as a cardiologist on staff with Carson Tahoe Health. Dr. Continue reading →

Remote monitoring and high-tech health management solutions have dominated cardiology headlines for the better part of the past year, touted for their accessibility and preventive benefits. But that vision of remote monitoring as the future of CV care might be a skewed representation of our current reality Continue reading →